Among hematologic malignancies, BCL-W is highly expressed in a subset of c-MYC-expressing DLBCL and Burkitt lymphomas as well as B-CLL cells, although it appears dispensable for their survival [176,178]. The gene discussed is MYC; the disease is Burkitt lymphoma.